🌐 pozelimab
Pozelimab is a monoclonal antibody developed to inhibit complement component C5, monitored globally as a biopharmaceutical asset and treatment for rare complement-mediated disorders.
1
Signals
1
Articles
Linked Signals
| Signal | Status | Lens | Role | Confidence | Last Seen |
|---|---|---|---|---|---|
| Seven-minute virtual reality intervention helps students tackle stress and exam anxiety | expired | Health | involved | 100% |